Skip to main content

Validation study of the claims-based definition for age-related macular degeneration at a single university hospital in Japan

Abstract

Purpose

To evaluate the efficacy of the claims’-based definition of age-related macular degeneration (AMD) in detecting clinically-diagnosed AMD.

Study design

A validation study using cross-sectional data.

Methods

Seven hundred clinically-diagnosed AMD patients and seven hundred non-AMD individuals were randomly selected from patients at the Kyoto University Hospital’s ophthalmology outpatient clinic between January 2011 and December 2017. We evaluated the sensitivity, specificity, and positive/negative likelihood ratio of eight different claims’-based definitions of AMD for detecting clinically-diagnosed AMD. These definitions consist of the diagnosis name (AMD) in combination with (1) fluorescent fundus angiography, and/or (2) treatment of AMD, and (3) the exclusion of patients who had a diagnosis of central serous chorioretinopathy (CSC) or myopic choroidal neovascularization.

Results

Defining by the diagnosis name AMD in the claims’ data showed the highest accuracy (sensitivity 94.9%, specificity 92.6%, accuracy 93.7%). Combining the diagnosis name AMD with fluorescence fundus angiography and/or anti-vascular endothelial growth factor (anti VEGF) treatment increased the specificity at the expense of sensitivity. Notably, the combination with AMD treatment achieved a specificity of 98.3%.

Conclusion

The current validation study elucidated the high accuracy of the disease name (AMD) in the claims’ data for identifying clinically-diagnosed AMD at a single university hospital. Although drawing wider conclusions may be limited, the results of this study contribute to creating real-world evidence in ophthalmology, based on the National Database of Health Insurance Claims in Japan.

This is a preview of subscription content, access via your institution.

Fig. 1

References

  1. 1.

    Kawasaki R, Wang JJ, Ji GJ, Taylor B, Oizumi T, Daimon M, et al. Prevalence and risk factors for age-related macular degeneration in an adult Japanese population: the Funagata study. Ophthalmology. 2008; 115:1376–81, 81 e1–2.

  2. 2.

    Kawasaki R, Yasuda M, Song SJ, Chen SJ, Jonas JB, Wang JJ, et al. The prevalence of age-related macular degeneration in Asians: a systematic review and meta-analysis. Ophthalmology. 2010;117:921–7.

    Article  Google Scholar 

  3. 3.

    Varma R, Fraser-Bell S, Tan S, Klein R, Azen SP, Los Angeles Latino Eye Study G. Prevalence of age-related macular degeneration in Latinos: the Los Angeles Latino eye study. Ophthalmology. 2004; 111:1288–97.

  4. 4.

    Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy. The Beaver Dam Eye Study Ophthalmol. 1992;99:933–43.

    CAS  Google Scholar 

  5. 5.

    Vingerling JR, Dielemans I, Hofman A, Grobbee DE, Hijmering M, Kramer CF, et al. The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology. 1995;102:205–10.

    CAS  Article  Google Scholar 

  6. 6.

    Mitchell P, Smith W, Attebo K, Wang JJ. Prevalence of age-related maculopathy in Australia. Blue Mount Eye Study Ophthalmol. 1995;102:1450–60.

    CAS  Google Scholar 

  7. 7.

    Nakata I, Yamashiro K, Nakanishi H, Akagi-Kurashige Y, Miyake M, Tsujikawa A, et al. Prevalence and characteristics of age-related macular degeneration in the Japanese population: the Nagahama study. Am J Ophthalmol. 2013;156(1002–9):e2.

    Google Scholar 

  8. 8.

    Ikegami N, Yoo BK, Hashimoto H, Matsumoto M, Ogata H, Babazono A, et al. Japanese universal health coverage: evolution, achievements, and challenges. Lancet. 2011;378:1106–15.

    Article  Google Scholar 

  9. 9.

    Kwon S. Thirty years of national health insurance in South Korea: lessons for achieving universal health care coverage. Health Policy Plan. 2009;24:63–71.

    Article  Google Scholar 

  10. 10.

    Wu TY, Majeed A, Kuo KN. An overview of the healthcare system in Taiwan. Lond J Prim Care (Abingdon). 2010;3:115–9.

    Article  Google Scholar 

  11. 11.

    Park SJ, Kwon KE, Choi NK, Park KH, Woo SJ. Prevalence and incidence of exudative age-related macular degeneration in South Korea: a nationwide population-based study. Ophthalmology. 2015;122:2063–70.

    Article  Google Scholar 

  12. 12.

    Kubo S, Noda T, Myojin T, Yuichi N, Higashino T, Matsui H, et al. National database of health insurance claims and specific health checkups of Japan (NDB): outline and patient-matching technique. bioRxiv. 2018. https://doi.org/10.1101/280008.

  13. 13.

    Kato G. History of the secondary use of national database of health insurance claims and specific health checkups of Japan (NDB). Trans Jpn Soc Med Biol Eng. 2017;55:143–50.

    Google Scholar 

  14. 14.

    Cheng CL, Lee CH, Chen PS, Li YH, Lin SJ, Yang YH. Validation of acute myocardial infarction cases in the national health insurance research database in taiwan. J Epidemiol. 2014;24:500–7.

    Article  Google Scholar 

  15. 15.

    Kern DM, Davis J, Williams SA, Tunceli O, Wu B, Hollis S, et al. Validation of an administrative claims’s-based diagnostic code for pneumonia in a US-based commercially insured COPD population. Int J Chron Obstruct Pulmon Dis. 2015;10:1417–25.

    CAS  Article  Google Scholar 

  16. 16.

    Ando T, Ooba N, Mochizuki M, Koide D, Kimura K, Lee SL, et al. Positive predictive value of ICD-10 codes for acute myocardial infarction in Japan: a validation study at a single center. BMC Health Serv Res. 2018;18:895.

    Article  Google Scholar 

  17. 17.

    Hosoda Y, Miyake M, Schellevis RL, Boon CJF, Hoyng CB, Miki A, et al. Genome-wide association analyses identify two susceptibility loci for pachychoroid disease central serous chorioretinopathy. Commun Biol. 2019;2:468.

    CAS  Article  Google Scholar 

  18. 18.

    Hosoda Y, Yoshikawa M, Miyake M, Tabara Y, Ahn J, Woo SJ, et al. CFH and VIPR2 as susceptibility loci in choroidal thickness and pachychoroid disease central serous chorioretinopathy. Proc Natl Acad Sci USA. 2018;115:6261–6.

    CAS  Article  Google Scholar 

  19. 19.

    Miyake M, Ooto S, Yamashiro K, Takahashi A, Yoshikawa M, Akagi-Kurashige Y, et al. Pachychoroid neovasculopathy and age-related macular degeneration. Sci Rep. 2015;5:16204.

    CAS  Article  Google Scholar 

  20. 20.

    Miyake M, Tsujikawa A, Yamashiro K, Ooto S, Oishi A, Tamura H, et al. Choroidal neovascularization in eyes with choroidal vascular hyperpermeability. Invest Ophthalmol Vis Sci. 2014;55:3223–30.

    Article  Google Scholar 

  21. 21.

    Miyake M, Yamashiro K, Akagi-Kurashige Y, Kumagai K, Nakata I, Nakanishi H, et al. Vascular endothelial growth factor gene and the response to anti-vascular endothelial growth factor treatment for choroidal neovascularization in high myopia. Ophthalmology. 2014;121:225–33.

    Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Masahiro Miyake.

Ethics declarations

Conflicts of interest

R. Tamiya, None; M. Miyake, Consultant fee, Lecture fee (Santen, Nevakar, Novartis, Alcon, HOYA, Kowa, Senju, Ellex, Johnson & Johnson, AMO); A. Kido, None; S. Hiragi, None; H. Tamura, Grant (Findex), Lecture fee, Non-financial support (Novartis), Non-financial support (Bayer, Santen); T. Kuroda, None; A. Tsujikawa, Grant, Consultant fee, Lecture fee (Canon, AMO, Wakamoto, Otsuka), Grant (Findex, Kowa, Pfizer, TOMEY, Taiho), Grant, Advisory Board fee (Santen, Senju, Alcon), Advisory Board fee (HOYA, Bayer, Novartis, Chugai, Astellas, Eisai, Daiich-Sankyo, Janssen, Kyoto Drug Discovery & Development, Allergan), Consultant fee, Lecture fee (Sanwa Kagaku Kenkyusho, Nitten, Otsuka).

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Corresponding Author: Masahiro Miyake

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 16 KB)

About this article

Verify currency and authenticity via CrossMark

Cite this article

Tamiya, R., Miyake, M., Kido, A. et al. Validation study of the claims-based definition for age-related macular degeneration at a single university hospital in Japan. Jpn J Ophthalmol 65, 388–394 (2021). https://doi.org/10.1007/s10384-021-00816-w

Download citation

Keywords

  • Electronic medical record
  • Claim database
  • Validation
  • Clinical research
  • NDB